Impaired cell surface expression of GLP1R variants determines T2D and obesity risk in humans
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Physiology (medical),Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://www.nature.com/articles/s42255-023-00888-7.pdf
Reference5 articles.
1. Nauck, M. A., Quast, D. R., Wefers, J. & Meier, J. J. GLP-1 receptor agonists in the treatment of type 2 diabetes — state-of-the-art. Mol. Metab. 46, 101102 (2021). A review that discusses the latest GLP1R-based treatments.
2. El Eid, L., Reynolds, C. A., Tomas, A. & Jones, B. Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics. Pharmacol. Res. 184, 106411 (2022). A review that presents existing GLP1R variants and future therapeutic options.
3. Bonnefond, A. et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat. Genet. 44, 297–301 (2012). This paper reports a large-scale functional genetics study on rare GPCR variants.
4. Nogueiras, R., Nauck, M. A. & Tschop, M. H. Gut hormone co-agonists for the treatment of obesity: from bench to bedside. Nat. Metab. 5, 933–944 (2023). A review that presents recent advances in the clinical application of dual and triple GLP1R agonists.
5. Ulloa-Aguirre, A., Zarinan, T., Gutierrez-Sagal, R. & Tao, Y. X. Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases. Front. Endocrinol. (Lausanne) 13, 934685 (2022). A review that presents the state-of-the-art of pharmacological chaperones for GPCRs.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3